Merck & Co., Inc. (LON:MRK)

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of GBP 196.56 billion. The enterprise value is 214.10 billion.

Market Cap	196.56B
Enterprise Value	214.10B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.91%
Shares Change (QoQ)	-0.60%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	79.22%
Float	2.48B

Valuation Ratios

The trailing PE ratio is 13.88 and the forward PE ratio is 11.62.

PE Ratio	13.88
Forward PE	11.62
PS Ratio	4.11
PB Ratio	5.09
P/TBV Ratio	17.67
P/FCF Ratio	20.25
P/OCF Ratio	15.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.89, with an EV/FCF ratio of 22.05.

EV / Earnings	15.12
EV / Sales	4.41
EV / EBITDA	8.89
EV / EBIT	10.42
EV / FCF	22.05

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.80.

Current Ratio	1.66
Quick Ratio	1.09
Debt / Equity	0.80
Debt / EBITDA	1.30
Debt / FCF	3.17
Interest Coverage	21.34

Financial Efficiency

Return on equity (ROE) is 39.49% and return on invested capital (ROIC) is 19.31%.

Return on Equity (ROE)	39.49%
Return on Assets (ROA)	13.76%
Return on Invested Capital (ROIC)	19.31%
Return on Capital Employed (ROCE)	26.94%
Revenue Per Employee	645,770
Profits Per Employee	191,353
Employee Count	75,000
Asset Turnover	0.52
Inventory Turnover	2.24

Taxes

In the past 12 months, Merck & Co. has paid 2.06 billion in taxes.

Income Tax	2.06B
Effective Tax Rate	12.71%

Stock Price Statistics

The stock price has decreased by -13.59% in the last 52 weeks. The beta is 0.66, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-13.59%
50-Day Moving Average	49.80
200-Day Moving Average	56.65
Relative Strength Index (RSI)	16.96
Average Volume (20 Days)	366,966

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.11

Income Statement

In the last 12 months, Merck & Co. had revenue of GBP 47.79 billion and earned 14.16 billion in profits. Earnings per share was 5.62.

Revenue	47.79B
Gross Profit	37.20B
Operating Income	20.23B
Pretax Income	16.23B
Net Income	14.16B
EBITDA	23.45B
EBIT	20.23B
Earnings Per Share (EPS)	5.62

Balance Sheet

The company has 13.55 billion in cash and 30.78 billion in debt, giving a net cash position of -17.23 billion.

Cash & Cash Equivalents	13.55B
Total Debt	30.78B
Net Cash	-17.23B
Net Cash Per Share	n/a
Equity (Book Value)	38.62B
Book Value Per Share	15.51
Working Capital	14.08B

Cash Flow

In the last 12 months, operating cash flow was 12.70 billion and capital expenditures -2.99 billion, giving a free cash flow of 9.71 billion.

Operating Cash Flow	12.70B
Capital Expenditures	-2.99B
Free Cash Flow	9.71B
FCF Per Share	n/a

Margins

Gross margin is 77.85%, with operating and profit margins of 42.33% and 29.63%.

Gross Margin	77.85%
Operating Margin	42.33%
Pretax Margin	33.96%
Profit Margin	29.63%
EBITDA Margin	49.07%
EBIT Margin	42.33%
FCF Margin	20.31%

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	42.60%
Buyback Yield	0.91%
Shareholder Yield	0.91%
Earnings Yield	7.20%
FCF Yield	4.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.89 and a Piotroski F-Score of 5.

Altman Z-Score	3.89
Piotroski F-Score	5